Hemab Therapeutics Holdings, Inc. COAG
NASDAQ · United States · Health Technology
$31.06+0.22 (+0.71%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.80 | -0.73 | -9.2% | $0 | — | +7.2%$49.87→$53.48 |
| Q1 2026 | 2026-05-21 | -23.98 | — | — | — | — | -2.2%$26.47→$25.89 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.